A preliminary analysis of the TIME and PD-1/PD-L1 therapeutic reactivity in the BLCA patients indicated that OBSCN expression deficiency may induce the BLCA to recruit more CD8+T cells. This evidence concerns the gene CD8A and bladder transitional cell carcinoma.